AKT1 and Alzheimer disease: AD pathology consists of Aβ deposits accumulating in the brain initiating a cascade of events which include: the release of inflammatory cytokines from microglia, the activation of Rac and Rho GTPases, and numerous downstream effects (including inflammatory component IL-1β) all resulting in the cognitive decline associated with the disease.